Oncology Roundtable: Treating MF and PV in 2023
Oncology Roundtable: Treating MF and PV in 2023 is organized by Physicians' Education Resource, LLC (PER).
Release Date: January 31, 2023
Expiration Date: January 31, 2024.
Description:
This online, on-demand virtual symposium brings together renowned experts in the management of myeloproliferative neoplasms (MPNs), such as myelofibrosis (MF) and polycythemia vera (PV). In this educational program, these experts discuss recent data presentations and how emerging treatment approaches are impacting the treatment landscape. This discussion is framed in the context of challenging case discussions presented by the faculty, providing a forum for the audience to learn how new data should be incorporated into practice.
This educational activity is an archive of the live symposium held on January 13, 2023.
Learning Objectives:
Upon successful completion of this activity, you should be better prepared to:
• Outline factors that influence treatment selection in patients with MF and PV based on genetics, risk stratification, and symptom burden
• Determine the efficacy and safety of current and emerging therapeutic strategies in MPNs across lines of therapy
• Assess recent evidence in the context of evolving standards of care in MPNs
• Employ recent evidence to create individualized treatment plans and manage treatment-associated toxicities in patients with MF and PV.
Additional details will be posted as soon as information is available.